Trout Capital

About us

The Trout Group has helped hundreds of public and private companies of all sizes and stages of development achieve their investor relations goals. From our headquarters in New York and offices in Boston, San Francisco, London, Shanghai and Sydney, Trout’s professionals currently serve more than 70 clients from around the world.  We provide our clients in the life sciences and energy technology sectors with expert counsel and access to the institutional investment community.

Trout Capital: Annual 1x1 Management Access Event Trout Capital: Investor Relations Excellence Trout Capital: Relationship Capital

Annual 1x1 Management Access Event

The Trout Group is pleased to announce our Annual 1x1 Management Access Event in San Francisco. More than 80 companies will be available for 1x1 meetings at this year’s event. To register, click learn more or email us at TroutSF1x1@troutgroup.com.

Learn More learn more

Investor Relations Excellence

Companies call us when they require reliable investor relations counsel and support delivered with a perspective specific to life sciences or energy technology companies. Large or small, our clients benefit from our wealth of knowledge and passion for helping.

Learn More learn more

Relationship Capital

The Trout Group is a leading investor relations and strategic advisory firm exclusively serving the life sciences and energy technology industries. Since 1996, Trout has been providing companies in the sector with access to the institutional investment community.

Learn More learn more

Conferences & Events

Download iCal

November 21, 2014 • Washington , DC, US

PDUFA: Intermune’s Esbriet in Idiopathic Pulmonary Fibrosis

Download iCal

November 21, 2014 • Washington , DC, US

PDUFA: Intermune’s Esbriet in Idiopathic Pulmonary Fibrosis

Download iCal

November 24, 2014 • New York, New York,

Download iCal

November 24, 2014 - November 26, 2014 • Frankfurt, Germany

Download iCal

November 26, 2014 - October 26, 2014 • Washington, DC, US

PDUFA: Avanir’s AVP-825 for Acute Treatment of Migraine

Download iCal

November 28, 2014 • Washington, DC, US

PDUFA: Bristol-Myers' Asunaprevir and Daclatasvir in HCV

View All Events & Conferences

Our Clients

  • Reneuron

    Reneuron

    UK

  • Affimed

    Affimed

    Germany

  • Pieris AG

    Pieris AG

    Germany

  • Genfit

    Genfit

    France

  • Keryx Biopharmaceuticals

    Keryx Biopharmaceuticals

    US

  • VIVUS Inc.

    VIVUS Inc.

    US

  • Repros Therapeutics Inc.

    Repros Therapeutics Inc.

    US

  • Celsus Therapeutics

    Celsus Therapeutics

    US

  • Ascendis Pharma

    Ascendis Pharma

    US

  • DBV Technologies

    DBV Technologies

    France

  • Sutro Biopharma, Inc.

    Sutro Biopharma, Inc.

    US

  • Poxel

    Poxel

    France

View All Clients